Wang J L, Sun Y, Wang Y, Wu Y, Liu F
West China Hospital of Sichuan University, Division of Nephrology, Chengdu, China.
Mianyang Central Hospital, Division of Nephrology, Mianyang, China.
Acta Endocrinol (Buchar). 2022 Jan-Mar;18(1):29-34. doi: 10.4183/aeb.2022.29.
This study investigated the relationship between proteinuria levels, clinicopathological features, and renal prognoses in Chinese patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN).
Three hundred patients with T2DM and biopsy-proven DN were enrolled. Patients were stratified by 24-h proteinuria levels: Group 1:≤1g/24h); Group 2:1-3g/24h; and Group 3:≥3g/24h. Renal outcomes were defined as having reached end-stage renal disease (ESRD). The proteinuria level's influence on the renal outcomes was evaluated using Cox regression analysis.
Among subgroups stratified by proteinuria levels, systolic blood pressure, serum creatinine, BUN, cholesterol, DR and hypertension incidence, the incidences of patients who progressed to ESRD were the lowest in group 1 (P<0.05). However, eGFR, serum albumin and hemoglobin were highest in group 1. Patients with higher proteinuria levels had much lower five-year renal survival rates. Univariate analyses revealed that higher proteinuria levels were significant clinical predictors of renal prognosis (P<0.05), although they were not independent risk factors for progression to ESRD in the multivariate Cox proportional hazard analysis (P>0.05).
The higher the level of proteinuria, the lower the 5-year renal survival rate of DN patients, but there was no significant correlation between proteinuria level and 5-year renal survival rate. Other factors in the proteinuria group may have more significant effects on the 5-year renal survival rate, such as lower baseline eGFR, serum albumin, hemoglobin and higher cholesterol, higher incidences of DR and more severe lesions.
本研究调查了中国2型糖尿病(T2DM)和糖尿病肾病(DN)患者蛋白尿水平、临床病理特征与肾脏预后之间的关系。
纳入300例经活检证实为DN的T2DM患者。根据24小时蛋白尿水平将患者分层:第1组:≤1g/24小时;第2组:1 - 3g/24小时;第3组:≥3g/24小时。肾脏结局定义为达到终末期肾病(ESRD)。采用Cox回归分析评估蛋白尿水平对肾脏结局的影响。
在按蛋白尿水平分层的亚组中,收缩压、血清肌酐、尿素氮、胆固醇、糖尿病视网膜病变(DR)和高血压发病率方面,进展至ESRD的患者发生率在第1组中最低(P<0.05)。然而,估算肾小球滤过率(eGFR)、血清白蛋白和血红蛋白在第1组中最高。蛋白尿水平较高的患者五年肾脏生存率低得多。单因素分析显示较高的蛋白尿水平是肾脏预后的显著临床预测因素(P<0.05),尽管在多变量Cox比例风险分析中它们不是进展至ESRD的独立危险因素(P>0.05)。
蛋白尿水平越高,DN患者的五年肾脏生存率越低,但蛋白尿水平与五年肾脏生存率之间无显著相关性。蛋白尿组中的其他因素可能对五年肾脏生存率有更显著影响,如较低的基线eGFR、血清白蛋白、血红蛋白以及较高的胆固醇、较高的DR发生率和更严重的病变。